I Plan | 5 | 0 |
I−1 Assess patient's personal characteristics | 5 | 0 |
I−1−1 Demographic characteristics include date of birth, age of diagnosis, date of diagnosis, BMI, marital status, child status, education level, medical insurance status, per capita income, religious beliefs, past medical history (including the six major systems, cardiovascular system, nervous system, respiratory system, digestive system, blood system, endocrine system), commonly used drugs. | 4.75 ± 0.44 | 0.09 |
I−1−2 Disease related features include PSA, testosterone, pathological results, biochemistry, blood routine, urine routine, prostate MRI, whole body bone scan, abdominal ultrasound, pet-CT, TNM staging of metastatic patients, whether frequent urination, urgency, painful urination, and difficulty urinating during each examination (re examination). | 4.60 ± 0.50 | 0.11 |
I−2 Assess patient related experiences | 5 | 0 |
I−2−1 Compliance behavior | 4.80 ± 0.41 | 0.09 |
I−2−2 The mastery of disease-related knowledge includes basic knowledge of the disease, knowledge or side effects related to the treatment of complications, medication knowledge, usage of diapers, and response measures for changes in urination morphology. | 4.90 ± 0.31 | 0.06 |
I−3 Assess patient's behavioral cognition | 5 | 0 |
I−3−1 Self-efficacy (Self-efficacy Questionnaire) | 4.80 ± 0.41 | 0.09 |
I−3−2 Coping Strategies (Medical coping questionnaire) | 4.75 ± 0.44 | 0.09 |
I−4 Treatment methods | 4.80 ± 0.41 | 0.09 |
I−4−1 Preferred treatment plan | 4.50 ± 0.61 | 0.14 |
I−4−2 Surgical method, lymph node dissection, preservation of nerves, indwelling of pipelines, perioperative complications, postoperative diagnosis. | 4.65 ± 0.59 | 0.13 |
I−5 Draw up the plan | 5 | 0 |
I−5−1 Develop 5W1H content, including what to do, why to do it, who to do it, when to do it, where to do it, and how to do it, and jointly formulate goals. | 4.60 ± 0.60 | 0.13 |
Ⅱ Do | 5 | 0 |
Ⅱ−1 Enhance awareness of health responsibility | 5 | 0 |
Ⅱ−1−1 Introduce prostate cancer related knowledge to patients. | 4.90 ± 0.31 | 0.06 |
Ⅱ−1−2 Introduce postoperative urinary incontinence nursing knowledge to patients. | 4.90 ± 0.31 | 0.06 |
Ⅱ−1−3 Introduce patients to issues related to sexual function. | 4.80 ± 0.41 | 0.09 |
Ⅱ−1−4 Introduce common side effects and coping strategies of endocrine therapy to patients, including hot flashes, metabolic syndrome, cognitive impairment, osteoporosis, anemia, etc | 4.85 ± 0.37 | 0.08 |
Ⅱ−1−5 Introduce the common side effects and coping strategies of chemotherapy treatment to patients, including nausea, vomiting, diarrhea, bone marrow depression, fluid retention, exoneurotoxicity, etc | 4.85 ± 0.37 | 0.08 |
Ⅱ−1−6 Introduce common side effects and countermeasures of radiotherapy to patients, including hematuria, proctitis, etc | 4.60 ± 0.68 | 0.15 |
Ⅱ−1−7 Introduce the medication instructions for common medications to patients, such as the principle of adjusting the dosage of abiraterone and medication testing items. | 4.90 ± 0.31 | 0.06 |
Ⅱ−1−8 Introduce knowledge related to wound and pipeline care to patients. | 4.85 ± 0.37 | 0.08 |
Ⅱ−2 Strengthen nutrition management | 5 | 0 |
Ⅱ−2−1 Risk assessment and screening (NRS 2002) | 4.40 ± 0.60 | 0.14 |
Ⅱ−2−2 Development of a multidisciplinary, collaborative, personalized nutrition program. | 4.60 ± 0.60 | 0.13 |
Ⅱ−2−3 Personalized nutrition related health education. | 4.65 ± 0.59 | 0.13 |
Ⅱ−3 Improve your stress response skills | 5 | 0 |
Ⅱ−3−1 Adopting solution-focused brief counseling | 4.60 ± 0.68 | 0.15 |
Ⅱ−3−2 If the patient experiences pain, mindfulness therapy can be adopted | 4.70 ± 0.66 | 0.14 |
Ⅱ−4 Methods of Exercise | 5 | 0 |
Ⅱ−4−1 According to the patient's condition, aerobic exercise such as jogging, swimming, walking, etc. can be performed | 4.85 ± 0.49 | 0.10 |
Ⅱ−4−2 Postoperative impedance training such as hip bridge transformation, prone hip extension, and kneeling hip extension should be performed twice a day for 20 minutes each time. | 4.80 ± 0.52 | 0.11 |
Ⅱ−4−3 Exercise precautions for patients with bone metastasis: mainly to avoid falls and fractures. | 4.55 ± 0.69 | 0.15 |
Ⅱ−5 Strengthen interpersonal support | 5 | 0 |
Ⅱ−5−1 Family support: to provide education and training for family members. | 4.75 ± 0.55 | 0.16 |
Ⅱ−5−2 Patient support: establish patient wechat group and hold regular patient communication meetings. | 4.55 ± 0.83 | 0.18 |
Ⅱ−5−3 Medical staff support: information push, interaction, and dynamic follow-up monitoring of patients' conditions. | 4.75 ± 0.44 | 0.09 |
Ⅱ−5−4 Social support: such as community attention, free medical treatment, etc | 4.65 ± 0.58 | 0.12 |
Ⅲ Check | 5 | 0 |
Ⅲ−1 Quality of life assessment | 5 | 0 |
Ⅲ−1−1 Health Promotion of Lifestyle (HPLP-Ⅱ) | 4.35 ± 0.49 | 0.11 |
Ⅲ−1−2 Exercise endurance (6-min walking distance) | 4.20 ± 0.83 | 0.19 |
Ⅲ−1−3 Self-management Ability Assessment (CDSCA) | 4.70 ± 0.57 | 0.12 |
Ⅲ−1−4 Nutrition Assessment (SGA) | 4.65 ± 0.59 | 0.13 |
Ⅲ−2 Psychological status assessment | 5 | 0 |
Ⅲ−2−1 Sleep (PSQI) | 4.85 ± 0.37 | 0.08 |
Ⅲ−2−2 Anxiety condition (GAD−7) | 4.55 ± 0.69 | 0.15 |
Ⅲ−2−3 Depression condition (PHQ−9) | 4.50 ± 0.69 | 0.15 |
Ⅲ−3 Evaluation of specific postoperative conditions for prostate cancer | 5 | 0 |
Ⅲ−3−1 Erectile Function Assessment (IIEF−5) | 3.8 ± 0.70 | 0.18 |
Ⅲ−3−2 Voiding Functional Assessment (IPSS) | 4.80 ± 0.41 | 0.09 |
Ⅳ Action | 5 | 0 |
Ⅳ−1 The condition is stable | 5 | 0 |
Ⅳ−1−1 Regular follow-up (monthly review for the first three months after the end of the first treatment, and review for every three months thereafter), and medical cooperation | 4.75 ± 0.44 | 0.09 |
Ⅳ−2 Relapse, metastasis, and aggravated symptoms | 5 | 0 |
Ⅳ−2−1 Multidisciplinary cooperation to adjust the treatment plan according to the patient's condition | 4.95 ± 0.22 | 0.04 |
Ⅳ−2−2 Metastasis: such as bone metastasis and compression to the nerve, referral to orthopedic treatment | 4.75 ± 0.55 | 0.12 |